Confidential Client Pharmaceutical Production Decarbonization

A leading pharmaceutical manufacturer is undertaking a major expansion of its US production capacity while advancing their commitment to become carbon-neutral in its operations (Scope 1 and 2 emissions) by 2030. Salas O’Brien is providing planning, performance verification, cost-benefit analysis, and design for phased campus energy system transformations, integrated with existing infrastructure.

The plans leverage the simultaneous heating and cooling loads characteristic of manufacturing campuses via heat pumps, joined in a resilient, low-temperature hot water thermal energy network (TEN) to provide energy sharing and load balancing. Plans prioritize internal energy redistribution before deploying open-loop geothermal heat exchange systems. Upon completion, the campus systems will meet over 80% of heat demand internally, reducing life cycle costs while supporting long-term sustainability goals.